Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00875329 · ClinicalTrials.gov registry record

Traumatic Brain Injury (TBI) Screening Instruments

A clinical trial, sponsored by US Department of Veterans Affairs.

Completed
Registry status
97
Enrollment target

NCT00875329: Completed study, sponsored by US Department of Veterans Affairs.

NCT00875329 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00875329 has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
97 participants
Enrollment target

Study Summary

Goal: The ultimate goal of this research program is to improve the health and quality of life for wounded warriors from Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) through screening, risk assessment, and outcome measurement. Purpose: The purpose of this study is to evaluate the reliability and validity of the existing Traumatic Brain Injury (TBI) Clinical Reminder Screen for OEF/OIF Veterans.

Primary Outcome

The presence or absence of symptomatic TBI as determined by the VA TBI Clinical Reminder screen was compared to presence or absence of a deployment-related TBI as determined by the study's criterion standard (i.e., the VA TBI Clinical Identification Interview) to determine concordance and calculate sensitivity and specificity of the VA TBI Clinical Reminder screen. Sensitivity of the screen was the percent of positive screens of those determined to be true positives by the VA TBI Clinical Identi

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2010-09
Est. Completion 2015-02
US Department of Veterans Affairs

632 total trials

What the finished NCT00875329 record still lists

NCT00875329 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00875329 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00875329 about?

NCT00875329 is a clinical study titled "Traumatic Brain Injury (TBI) Screening Instruments". Goal: The ultimate goal of this research program is to improve the health and quality of life for wounded warriors from Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) through screening, risk assessment, and outcome measurement. Purpose: The purpose of this study is to evaluate the reliabil...

What is the current status of trial NCT00875329?

This trial is currently completed. The enrollment target is 97 participants. The study started on 2010-09. Estimated completion is 2015-02.

Who is sponsoring clinical trial NCT00875329?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03948490 · 97 participants · NA

    Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas

  • NCT04140487 · 97 participants · Phase 1

    Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

  • NCT04196413 · 97 participants · Phase 1

    GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

  • NCT05223816 · 97 participants · Phase 2

    An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00875329, the US trial registry maintained by the National Library of Medicine. NCT00875329 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.